From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors

Por Draghiciu, Oana, Nijman, Hans W., Daemen, Toos
Publicado em 2011

Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte Epitopes

Por Ip, Peng Peng, Nijman, Hans W., Daemen, Toos
Publicado no Vaccines (Basel) (2015)

Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy

Por Draghiciu, Oana, Lubbers, Joyce, Nijman, Hans W, Daemen, Toos
Publicado no Oncoimmunology (2015)

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

Por Draghiciu, Oana, Nijman, Hans W, Hoogeboom, Baukje Nynke, Meijerhof, Tjarko, Daemen, Toos
Publicado no Oncoimmunology (2015)

A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

Por Draghiciu, Oana, Boerma, Annemarie, Hoogeboom, Baukje Nynke, Nijman, Hans W, Daemen, Toos
Publicado no Oncoimmunology (2015)

Alphavirus-based Vaccines Encoding Nonstructural Proteins of Hepatitis C Virus Induce Robust and Protective T-cell Responses

Por Ip, Peng Peng, Boerma, Annemarie, Regts, Joke, Meijerhof, Tjarko, Wilschut, Jan, Nijman, Hans W, Daemen, Toos
Publicado em 2014

Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival

Por Ferns, Debbie M, Kema, Ido P, Buist, Marrije R, Nijman, Hans W, Kenter, Gemma G, Jordanova, Ekaterina S
Publicado no Oncoimmunology (2015)

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

Por van de Wall, Stephanie, Walczak, Mateusz, van Rooij, Nienke, Hoogeboom, Baukje-Nynke, Meijerhof, Tjarko, Nijman, Hans W., Daemen, Toos
Publicado no Vaccines (Basel) (2015)

Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study

Por Versluis, Marco A.C., Pielsticker, Cindy, van der Aa, Maaike A., de Bruyn, Marco, Hollema, Harry, Nijman, Hans W.
Publicado no Oncology (2018)

Borderline tumours of the ovary: Common practice in the Netherlands

Por De Decker, Koen, ter Brugge, Henk G., Bart, Joost, Kruitwagen, Roy F.P.M., Nijman, Hans W., Kruse, Arnold-Jan
Publicado no Gynecol Oncol Rep (2018)

Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens

Por van de Wall, Stephanie, Ljungberg, Karl, Ip, Peng Peng, Boerma, Annemarie, Knudsen, Maria L., Nijman, Hans W., Liljeström, Peter, Daemen, Toos
Publicado no Oncoimmunology (2018)

Antigen‐specific active immunotherapy for ovarian cancer

Por Paijens, Sterre T, Leffers, Ninke, Daemen, Toos, Helfrich, Wijnand, Boezen, H Marike, Cohlen, Ben J, Melief, Cornelis JM, de Bruyn, Marco, Nijman, Hans W
Publicado no Cochrane Database Syst Rev (2018)

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival

Por Corvigno, Sara, Wisman, G. Bea A., Mezheyeuski, Artur, van der Zee, Ate G.J., Nijman, Hans W., Åvall-Lundqvist, Elisabeth, Östman, Arne, Dahlstrand, Hanna
Publicado no Oncotarget (2016)

CD20(+) T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer

Por de Bruyn, Marco, Wiersma, Valerie R, Wouters, Maartje C A, Samplonius, Douwe F, Klip, Harry G, Helfrich, Wijnand, Nijman, Hans W, Eggleton, Paul, Bremer, Edwin
Publicado no Oncoimmunology (2015)

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccinatio...

Por Westra Tjalke A, Stirbu-Wagner Irina, Dorsman Sara, Tutuhatunewa Eric D, de Vrij Edwin L, Nijman Hans W, Daemen Toos, Wilschut Jan C, Postma Maarten J
Publicado em 2013-02-01

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccinatio...

Por Westra, Tjalke A, Stirbu-Wagner, Irina, Dorsman, Sara, Tutuhatunewa, Eric D, de Vrij, Edwin L, Nijman, Hans W, Daemen, Toos, Wilschut, Jan C, Postma, Maarten J
Publicado em 2013

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

Por Röpke, Mads, Hald, Jesper, Guldberg, Per, Zeuthen, Jesper, Nørgaard, Lars, Fugger, Lars, Svejgaard, Arne, Burg, Sjoerd Van Der, Nijman, Hans W., Melief, Cornelis J. M., Claesson, Mogens H.
Publicado em 1996

Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death

Por Brunekreeft, Kim L, Strohm, Corinna, Gooden, Marloes J, Rybczynska, Anna A, Nijman, Hans W, Grigoleit, Götz U, Helfrich, Wijnand, Bremer, Edwin, Siegmund, Daniela, Wajant, Harald, de Bruyn, Marco
Publicado em 2014

Galectin-9 Activates and Expands Human T-Helper 1 Cells

Por Gooden, Marloes J. M., Wiersma, Valerie R., Samplonius, Douwe F., Gerssen, Jurjen, van Ginkel, Robert J., Nijman, Hans W., Hirashima, Mitsuomi, Niki, Toshiro, Eggleton, Paul, Helfrich, Wijnand, Bremer, Edwin
Publicado em 2013

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer

Por Komdeur, Fenne L., Prins, Thalina M., van de Wall, Stephanie, Plat, Annechien, Wisman, G. Bea A., Hollema, Harry, Daemen, Toos, Church, David N., de Bruyn, Marco, Nijman, Hans W.
Publicado no Oncoimmunology (2017)